Pohl, J.; Litz, A.; El Ayoubi, O.; RodrÃguez-Alfonso, A.; Ständker, L.; Harms, M.; Münch, J.; Jumaa, H.; Datta, M.
An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci. 2024, 25, 8306.
https://doi.org/10.3390/ijms25158306
AMA Style
Pohl J, Litz A, El Ayoubi O, RodrÃguez-Alfonso A, Ständker L, Harms M, Münch J, Jumaa H, Datta M.
An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2024; 25(15):8306.
https://doi.org/10.3390/ijms25158306
Chicago/Turabian Style
Pohl, Johanna, Angela Litz, Omar El Ayoubi, Armando RodrÃguez-Alfonso, Ludger Ständker, Mirja Harms, Jan Münch, Hassan Jumaa, and Moumita Datta.
2024. "An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia" International Journal of Molecular Sciences 25, no. 15: 8306.
https://doi.org/10.3390/ijms25158306
APA Style
Pohl, J., Litz, A., El Ayoubi, O., RodrÃguez-Alfonso, A., Ständker, L., Harms, M., Münch, J., Jumaa, H., & Datta, M.
(2024). An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences, 25(15), 8306.
https://doi.org/10.3390/ijms25158306
